ProCE Banner Activity

Antibody–Drug Conjugates in Lung Cancer Care

Slideset Download
Download this brief slideset on what an antibody-drug conjugate is, along with how they may fit into the current treatment paradigm for lung cancer.

Released: February 07, 2022

Expiration: February 06, 2023

No longer available for credit.

Share

Faculty

Helena Yu

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Helena A. Yu, MD, has disclosed that she has received funds for research support paid to her institution from AstraZeneca, Cullinan Oncology, Daiichi Sankyo, Novartis, and Pfizer and consulting fees from AstraZeneca, Blueprint Medicine, Daiichi Sankyo, and Janssen Oncology.